Perrigo Management
Management criteria checks 3/4
Perrigo's CEO is Patrick Lockwood-Taylor, appointed in Jun 2023, has a tenure of less than a year. total yearly compensation is $6.67M, comprised of 9.1% salary and 90.9% bonuses, including company stock and options. directly owns 0.015% of the company’s shares, worth $616.34K. The average tenure of the management team and the board of directors is 7.2 years and 5 years respectively.
Key information
Patrick Lockwood-Taylor
Chief executive officer
US$6.7m
Total compensation
| CEO salary percentage | 9.1% |
| CEO tenure | less than a year |
| CEO ownership | 0.02% |
| Management average tenure | 7.2yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price
Mar 27
These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
Feb 01The Market Doesn't Like What It Sees From Perrigo Company plc's (NYSE:PRGO) Revenues Yet
Dec 28Perrigo's New Chapter: Its Bold Turnaround Plan Is Worth Buying
Nov 15The Prognosis For Perrigo
Aug 30Perrigo Outlook Healed By Repositioning
Jun 12Perrigo raises dividend by 5% to $0.273/share
Feb 21Perrigo: Still Languishing But Short-Term Trend Offers Encouragement
Jan 18Perrigo Non-GAAP EPS of $0.56 misses by $0.11, revenue of $1.1B misses by $40M, lowers FY adj. EPS guidance
Nov 08Perrigo to invest $170M to expand baby formula manufacturing, buys Nestlé Gateway plant
Nov 01Perrigo Company plc Is Back On Track
Oct 20Perrigo to face FDA AdCom meeting for OTC contraceptive
Sep 12Perrigo responds to 'misleading and inaccurate information' on Zantac claims
Aug 17Perrigo reports Q2 mixed results; raises FY22 organic net sales growth outlook
Aug 09Perrigo declares $0.26 dividend
Aug 02Perrigo: HRA Acquisition To Drive Significant Growth
Jul 20Perrigo unit seeks FDA over-the-counter approval for birth control pill Opill
Jul 11Perrigo: The Longer The Base The Higher In Space
Apr 12The Prognosis For Perrigo
Jan 09Perrigo: Honing In On A Long Term Bottom
Dec 16Perrigo Company plc (NYSE:PRGO) Shares Could Be 39% Below Their Intrinsic Value Estimate
Oct 17Perrigo: HRA Acquisition Is A Step In The Right Direction, But Fundamental Concerns Remain
Sep 24Here's Why Perrigo (NYSE:PRGO) Has A Meaningful Debt Burden
Jul 13Perrigo Company (PRGO) Presents At Evercore ISI Consumer & Retail Virtual Summit Conference - Slideshow
Jun 21Are Investors Undervaluing Perrigo Company plc (NYSE:PRGO) By 44%?
Jun 21Perrigo Q1 2021 Earnings Preview
May 10Perrigo - Simplifying To Unlock Appeal
May 02Perrigo (NYSE:PRGO) Seems To Use Debt Quite Sensibly
Apr 12Perrigo Company plc (NYSE:PRGO) Goes Ex-Dividend Soon
Mar 06Is There An Opportunity With Perrigo Company plc's (NYSE:PRGO) 35% Undervaluation?
Mar 04CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$7m | US$605k | -US$4m |
Compensation vs Market: Patrick's total compensation ($USD6.67M) is about average for companies of similar size in the US market ($USD6.66M).
Compensation vs Earnings: Insufficient data to compare Patrick's compensation with company performance.
CEO
Patrick Lockwood-Taylor
less than a year
Tenure
US$6,672,584
Compensation
Mr. Patrick Lockwood-Taylor has been President, Chief Executive Officer and Director at Perrigo Company plc since June 30, 2023. He had been Regional President and Head North American Consumer Health Busin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$6.67m | 0.015% $ 616.3k | |
| Executive VP & CFO | 1.9yrs | US$3.05m | 0.0089% $ 361.7k | |
| Chief Transformation Officer and Executive VP of Global Operations & Supply Chain | 8.5yrs | US$2.23m | 0.028% $ 1.2m | |
| Executive VP | 1.8yrs | US$2.28m | 0.0082% $ 334.9k | |
| Executive VP & President of Consumer Self-Care International | 7.2yrs | US$2.55m | 0.085% $ 3.4m | |
| Senior Director of Technical Operations | 12.6yrs | no data | no data | |
| Chief Information Officer & Executive VP | 17.5yrs | no data | 0.0079% $ 321.4k | |
| Executive VP & Chief Scientific Officer | 1.8yrs | no data | 0.013% $ 541.4k | |
| Vice President of Global Investor Relations & Corporate Communications | no data | no data | no data | |
| Director of Global Organizational and Human Resource Development | 16.3yrs | no data | no data | |
| Chief Human Resources Officer & Executive VP | 5.1yrs | no data | 0.023% $ 945.9k | |
| Executive VP & Chief Medical Officer | 8.4yrs | no data | 0.016% $ 633.4k |
7.2yrs
Average Tenure
55.5yo
Average Age
Experienced Management: PRGO's management team is seasoned and experienced (7.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$6.67m | 0.015% $ 616.3k | |
| Independent Director | 7.2yrs | US$399.99k | 0.014% $ 554.4k | |
| Independent Director | 9.4yrs | US$405.30k | 0.016% $ 665.2k | |
| Independent Director | 7.2yrs | US$387.49k | 0.023% $ 945.5k | |
| Independent Director | 1.8yrs | US$387.49k | 0.0021% $ 85.5k | |
| Independent Chairman of the Board | 3.3yrs | US$532.99k | 0.0074% $ 301.9k | |
| Director | less than a year | US$12.53k | no data | |
| Independent Director | 7.4yrs | US$387.49k | 0.035% $ 1.4m | |
| Independent Director | 5yrs | US$387.49k | 0.0095% $ 387.8k | |
| Independent Director | 6.9yrs | US$390.99k | 0.013% $ 538.9k | |
| Independent Director | 3.8yrs | US$392.80k | 0.0077% $ 312.9k |
5.0yrs
Average Tenure
60yo
Average Age
Experienced Board: PRGO's board of directors are considered experienced (5 years average tenure).